Comparing Flaxseed and Perindopril in the Prevention of Doxorubicin and Trastuzumab-Induced Cardiotoxicity in C57Bl/6 Mice

Background: Two anti-cancer agents, doxorubicin (DOX) and trastuzumab (TRZ), are commonly used in the management of breast cancer in women. Despite their efficacy in reducing the morbidity and mortality of individuals with breast cancer, the use of these agents is limited by adverse cardiotoxic side...

Descripción completa

Detalles Bibliográficos
Autores principales: Eekhoudt, Cameron R., Bortoluzzi, Tessa, Varghese, Sonu S., Cheung, David Y. C., Christie, Simon, Eastman, Skyler, Mittal, Ishika, Austria, J. Alejandro, Aukema, Harold M., Ravandi, Amir, Thliveris, James, Singal, Pawan K., Jassal, Davinder S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139942/
https://www.ncbi.nlm.nih.gov/pubmed/35621631
http://dx.doi.org/10.3390/curroncol29050241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139942/
https://www.ncbi.nlm.nih.gov/pubmed/35621631
http://dx.doi.org/10.3390/curroncol29050241

Ejemplares similares